Coumadin (Warfarin Sodium)


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 27.8%
Atrial Fibrillation 13.0%
Plasma Cell Myeloma 7.4%
Multiple Sclerosis 5.6%
Pulmonary Embolism 5.6%
Anticoagulant Therapy 3.7%
Coagulopathy 3.7%
Contraception 3.7%
Deep Vein Thrombosis 3.7%
Diuretic Therapy 3.7%
Headache 3.7%
Thrombosis Prophylaxis 3.7%
Arrhythmia Prophylaxis 1.9%
Bronchitis 1.9%
Cor Pulmonale Chronic 1.9%
Cough 1.9%
Depression 1.9%
Diabetic Foot Infection 1.9%
Hypercholesterolaemia 1.9%
Hypertension 1.9%
Thrombosis 12.0%
International Normalised Ratio Increased 8.0%
Renal Failure Chronic 8.0%
Urticaria 8.0%
Abdominal Wall Haematoma 4.0%
Device Related Infection 4.0%
Diarrhoea 4.0%
Dizziness 4.0%
Epistaxis 4.0%
Haemoptysis 4.0%
Haemorrhage 4.0%
Hypocoagulable State 4.0%
Infusion Site Infection 4.0%
Muscular Weakness 4.0%
Pneumonia 4.0%
Red Blood Cell Count Decreased 4.0%
Renal Failure Acute 4.0%
Respiratory Failure 4.0%
Seizure Like Phenomena 4.0%
Skin Disorder 4.0%
Concomitant
Pulmonary Arterial Hypertension 30.0%
Plasma Cell Myeloma 28.6%
Pulmonary Hypertension 5.9%
Cor Pulmonale Chronic 4.2%
Primary Pulmonary Hypertension 3.9%
Product Used For Unknown Indication 3.7%
Immunodeficiency Common Variable 3.0%
Prostate Cancer Metastatic 3.0%
Myelodysplastic Syndrome 2.2%
Depression 2.0%
Multiple Sclerosis 2.0%
Nephrogenic Anaemia 1.7%
Chronic Myeloid Leukaemia 1.5%
Hypertension 1.5%
Hypertension Arterial 1.2%
Gait Disturbance 1.2%
Hypertension Arterial 1.2%
Type 2 Diabetes Mellitus 1.2%
Amyloidosis 1.0%
Cardiac Failure 1.0%
Device Related Infection 14.7%
Death 14.1%
Pneumonia 12.5%
Vomiting 8.7%
Nausea 4.9%
Pulmonary Hypertension 4.3%
Thrombosis 4.3%
Dyspnoea 3.3%
Pulmonary Embolism 3.3%
Syncope 3.3%
Deep Vein Thrombosis 2.7%
Oedema Peripheral 2.7%
Pancytopenia 2.7%
Pyrexia 2.7%
Rash 2.7%
Renal Failure 2.7%
Sepsis 2.7%
Unresponsive To Stimuli 2.7%
Urinary Tract Infection 2.7%
Headache 2.2%

Drug Data